| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2094062 | NAT9 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=1 FDR=1 FC=-0.036 |
|
| 2094063 | NAT9 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=0.938 FDR=1 FC=0.004 |
|
| 2094064 | NAT9 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=1 FDR=1 FC=0.015 |
|
| 2094065 | NAP1L4 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.02 FDR=0.666 FC=0.015 |
